Literature DB >> 923634

Inhibition of lymphocyte proliferation by factor(s) produced by Schistosoma mansoni.

J P Dessaint, D Camus, E Fischer, A Capron.   

Abstract

Normal spleen cells of CBA mice or Fischer rats were cultured with mitogens or allogeneic cells, together with various substances of Schistosoma mansoni origin, and thymidine uptake was measured. The proliferation (DNA synthesis) of normal lymphocytes was inhibited by the incubation product of the parasite as well as by cell-free supernatant of schistosome culture. Inhibition was obtained only when active materials were added at the beginning of the culture. Both T and B cell proliferation were inhibited. The inhibitory activity found in cell-free supernatant suggested the release by the parasite of some factor(s) interfering with lymphocyte proliferation. Moreover, serum from rats infected by S. mansoni inhibited lymphocyte proliferation also. The inhibitor(s) appeared heat resistant, dialyzable and of low molecular weight (500-1000). Incubation of normal spleen cells with S. mansoni inhibitor(s) did not enhance the release of nonspecific suppressor cell factor. The inhibition of product(s) released by the parasite could explain part of the immunosuppression status found in schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923634     DOI: 10.1002/eji.1830070909

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Immune responses to Schistosoma mansoni in rhesus monkeys with multiple chronic and early primary infections.

Authors:  S E Maddison; S B Slemenda; G V Hillyer; F W Chandler; I G Kagan
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  The implantation of Taenia solium metacestodes in mice induces down-modulation of T-cell proliferation and cytokine production.

Authors:  Lilian Hernández-Mendoza; José Luis Molinari; Esperanza Garrido; Isabel Cortés; Sandra Solano; Enrique Miranda; Patricia Tato
Journal:  Parasitol Res       Date:  2005-01-28       Impact factor: 2.289

3.  Mechanisms of trypanosome-mediated suppression of humoral immunity in mice.

Authors:  J W Albright; J F Albright; D G Dusanic
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

4.  Suppression of antigen- and mitogen-induced proliferation of bovine lymphocytes by excretory-secretory products of Oesophagostomum radiatum.

Authors:  L C Gasbarre; R D Romanowski; F W Douvres
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

5.  Strain differences in lymphocyte responses and in vitro suppressor cell induction between Schistosoma mansoni-infected C57BL/6 and CBA mice.

Authors:  F A Lewis; E M Wilson
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

6.  Dipetalonema viteae infective larvae reach reproductive maturity in rats immunodepressed by prior exposure to Schistosoma mansoni or its products and in congenitally athymic rats.

Authors:  A Haque; D Camus; B M Ogilvie; M Capron; H Bazin; A Capron
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

7.  Schistosoma mansoni miracidial fluid inhibits human lymphocyte functions.

Authors:  J F Amador Pérez; P Wright
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

8.  Inhibition of lymphocyte activation by hatching fluid from Schistosoma mansoni eggs.

Authors:  E P Wright; C D Guthrie; D Salim; T J Hilditch; P K Das
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Immune depression in trypanosome-infected mice. IV. Kinetics of suppression and alleviation by the trypanocidal drug Berenil.

Authors:  G E Roelants; T W Pearson; W I Morrison; K S Mayor-Withey; L B Lundin
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

10.  An immunosuppressive factor in the serum of baboons (Papio anubis) infected with Schistosoma mansoni.

Authors:  B J Cottrell; R F Sturrock; M Vanhoegaerden
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.